CenExel operates an integrated, nationwide network of 18 Centers of Excellence that deliver end‑to‑end clinical research services for pharma, biotech, and CRO partners. With more than 40 years of experience, the company provides deep scientific expertise, premium data, and operational efficiencies that accelerate complex trial execution from site selection to close‑out. CenExel’s distinctive value stems from its unified site model, exceptional patient engagement, and commitment to real‑world solutions that drive successful outcomes for life‑changing therapies. Partners rely on CenExel to streamline logistics, enhance data integrity, and deliver measurable ROI across therapeutic areas such as neurology, mental health, and infectious disease. The company’s culture emphasizes collaboration, innovation, and a relentless focus on patient‑centric research.
CenExel is a leading nationwide clinical research site and patient network serving the life sciences industry. The Vice President of Business Development will lead CenExel’s Biotech Business Development function and serve as an individual contributor, developing and driving strategic sponsor/CRO relationships, overseeing Business Development team performance, and contributing directly to annual revenue growth.
CenExel operates an integrated, nationwide network of 18 Centers of Excellence that deliver end‑to‑end clinical research services for pharma, biotech, and CRO partners. With more than 40 years of experience, the company provides deep scientific expertise, premium data, and operational efficiencies that accelerate complex trial execution from site selection to close‑out. CenExel’s distinctive value stems from its unified site model, exceptional patient engagement, and commitment to real‑world solutions that drive successful outcomes for life‑changing therapies. Partners rely on CenExel to streamline logistics, enhance data integrity, and deliver measurable ROI across therapeutic areas such as neurology, mental health, and infectious disease. The company’s culture emphasizes collaboration, innovation, and a relentless focus on patient‑centric research.
gener8tor